2-aminoethoxyacetic acid derivatives and their use

Details 2-aminoethoxyacetic acid derivatives and their use 2-aminoethoxyacetic acid derivatives and their use

2011-04-26

2011-04-26

Saeed, Kamal A (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S229000

Reexamination Certificate

active

07932278

ABSTRACT:
The present application relates to novel 2-aminoethoxyacetic acid derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular thromboembolic disorders.

REFERENCES:
patent: 2811555 (1957-10-01), Larive et al.
patent: 3279880 (1966-10-01), Straley et al.
patent: 4128654 (1978-12-01), Fugitt et al.
patent: 4250318 (1981-02-01), Dostert et al.
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4500519 (1985-02-01), Lormeau et al.
patent: 4705779 (1987-11-01), Madi-Szabo et al.
patent: 4765989 (1988-08-01), Wong et al.
patent: 4948801 (1990-08-01), Carlson et al.
patent: 4977173 (1990-12-01), Brittelli et al.
patent: 5002937 (1991-03-01), Bosies et al.
patent: 5254577 (1993-10-01), Carlson et al.
patent: 5349045 (1994-09-01), Jiang
patent: 5532255 (1996-07-01), Raddatz et al.
patent: 5561148 (1996-10-01), Gante et al.
patent: 5565571 (1996-10-01), Barbachyn et al.
patent: 5654428 (1997-08-01), Barbachyn et al.
patent: 5654435 (1997-08-01), Barbachyn et al.
patent: 5688792 (1997-11-01), Barbachyn et al.
patent: 5756732 (1998-05-01), Barbachyn et al.
patent: 5792765 (1998-08-01), Riedl et al.
patent: 5801246 (1998-09-01), Barbachyn et al.
patent: 5827857 (1998-10-01), Riedl et al.
patent: 5910504 (1999-06-01), Hutchinson et al.
patent: 5922708 (1999-07-01), Riedl et al.
patent: 5929248 (1999-07-01), Barbachyn et al.
patent: 5935724 (1999-08-01), Spillman et al.
patent: 5972947 (1999-10-01), Tsaklakidis et al.
patent: 5977373 (1999-11-01), Gadwood et al.
patent: 5998406 (1999-12-01), Hester et al.
patent: 6069160 (2000-05-01), Stolle et al.
patent: 6159997 (2000-12-01), Tsujita et al.
patent: 6218413 (2001-04-01), Hester et al.
patent: 6251869 (2001-06-01), Bohanon
patent: 6265178 (2001-07-01), Martin, Jr.
patent: 6281210 (2001-08-01), Hester, Jr.
patent: 6294201 (2001-09-01), Kettelhoit et al.
patent: 6458793 (2002-10-01), Warner et al.
patent: 6805881 (2004-10-01), Kanikanti et al.
patent: 6818243 (2004-11-01), Nagashima et al.
patent: 7034017 (2006-04-01), Straub et al.
patent: 7078417 (2006-07-01), Rosentreter et al.
patent: 7109218 (2006-09-01), Rosentreter et al.
patent: 7129255 (2006-10-01), Rosentreter et al.
patent: 7157456 (2007-01-01), Straub et al.
patent: 2001/0029351 (2001-10-01), Falotico et al.
patent: 2001/0046987 (2001-11-01), Hester et al.
patent: 2003/0153610 (2003-08-01), Straub et al.
patent: 2003/0161882 (2003-08-01), Waterman
patent: 2004/0162427 (2004-08-01), Rosentreter et al.
patent: 2004/0242660 (2004-12-01), Straub et al.
patent: 2005/0064006 (2005-03-01), Perzborn et al.
patent: 2005/0182055 (2005-08-01), Berwe et al.
patent: 2005/0261502 (2005-11-01), Rosentreter et al.
patent: 2006/0154969 (2006-07-01), Rosentreter et al.
patent: 2006/0173047 (2006-08-01), Straub et al.
patent: 2006/0258724 (2006-11-01), Straub et al.
patent: 2007/0026065 (2007-02-01), Benke et al.
patent: 2007/0149522 (2007-06-01), Thomas
patent: 2008/0026057 (2008-01-01), Benke
patent: 2008/0090815 (2008-04-01), Straub et al.
patent: 2008/0200674 (2008-08-01), Straub et al.
patent: 744002 (2002-02-01), None
patent: 2836305 (1979-03-01), None
patent: 196 04 223 (1997-08-01), None
patent: 19962924 (2001-07-01), None
patent: 10105989 (2001-09-01), None
patent: 10105989 (2002-08-01), None
patent: 10129725 (2003-01-01), None
patent: 10355461 (2005-06-01), None
patent: 0 127 902 (1984-12-01), None
patent: 0 316 594 (1989-05-01), None
patent: 0 352 781 (1990-01-01), None
patent: 0350002 (1990-01-01), None
patent: 0623615 (1994-11-01), None
patent: 0645376 (1995-03-01), None
patent: 0738726 (1996-10-01), None
patent: 0 785 200 (1997-07-01), None
patent: 0930076 (1999-07-01), None
patent: 0950386 (1999-10-01), None
patent: 2140687 (1984-12-01), None
patent: WO-93/09103 (1993-05-01), None
patent: WO-93/23384 (1993-11-01), None
patent: WO-97/03072 (1997-01-01), None
patent: WO-97/09328 (1997-03-01), None
patent: WO-97/10223 (1997-03-01), None
patent: WO-98/01446 (1998-01-01), None
patent: WO-98/54161 (1998-12-01), None
patent: WO-99/02525 (1999-01-01), None
patent: WO-99/03846 (1999-01-01), None
patent: WO-99/06371 (1999-02-01), None
patent: WO-99/21535 (1999-05-01), None
patent: WO-99/24428 (1999-05-01), None
patent: WO-99/29688 (1999-06-01), None
patent: WO-99/31092 (1999-06-01), None
patent: WO-99/37304 (1999-07-01), None
patent: WO-99/37630 (1999-07-01), None
patent: WO-99/37641 (1999-07-01), None
patent: WO-99/40094 (1999-08-01), None
patent: WO-99/59616 (1999-11-01), None
patent: WO-00/16748 (2000-03-01), None
patent: 0147919 (2001-05-01), None
patent: WO-01/42242 (2001-06-01), None
patent: WO-01/44212 (2001-06-01), None
patent: WO-01/46185 (2001-06-01), None
patent: WO-01/47949 (2001-07-01), None
patent: WO-0147919 (2001-07-01), None
patent: WO-02/25210 (2002-03-01), None
patent: WO-02/064575 (2002-08-01), None
patent: WO-02/070484 (2002-09-01), None
patent: WO-02/070485 (2002-09-01), None
patent: WO-02/070520 (2002-09-01), None
patent: WO-02/079195 (2002-10-01), None
patent: WO-02/079196 (2002-10-01), None
patent: WO-03/000256 (2003-01-01), None
patent: WO-03/008384 (2003-01-01), None
patent: WO-03/035133 (2003-05-01), None
patent: WO-03/053441 (2003-07-01), None
patent: WO-2004/060887 (2004-07-01), None
patent: WO-2005/060940 (2005-05-01), None
patent: WO-2005/068456 (2005-07-01), None
patent: WO-2006/072367 (2006-07-01), None
patent: WO-2006/079474 (2006-08-01), None
patent: WO-2007/036306 (2007-04-01), None
patent: WO-2007/039122 (2007-04-01), None
patent: WO-2007/039132 (2007-04-01), None
patent: WO-2007/039134 (2007-04-01), None
patent: WO-2007/042146 (2007-04-01), None
patent: WO-2008/012002 (2008-01-01), None
patent: WO-2008/052671 (2008-05-01), None
Bono, F., et al., “Human Umbilical Vein Endothelial Cells Express High Affinity Receptors for Factor Xa”, Journal of Cellular Physiology, 1997, vol. 172, pp. 36-43.
Cocks, T. M., et al., “Protease-Activated Receptors: Sentries for Inflammation”, Tips, 2000, vol. 21, pp. 103-108.
Ross, R., “Atherosclerosis—An Inflammatory Disease”, New England J. of Medicine, 1999, vol. 340, No. 2, pp. 115-126.
Nakata, M., et al., “DX9065a an Xa Inhibitor, Inhibits Prothrombin-Induced A549 Lung Adenocarcinoma Cell Proliferation”, Cancer Letters, 1998, vol. 122, pp. 127-133.
Kaiser, B., et al., “A Synthetic Inhibitor of Factor Xa, DX-9065a, Reduces Proliferation of Vascular Smooth Muscle Cells in Vivo in Rats”, Thrombosis Research, 2000, vol. 98, pp. 175-185.
Altieri, D. C., et al., “Identification of Effector Cell Protease Receptor-1”, The Journal of Immunology, 1990, vol. 145, No. 1, pp. 246-253.
Coughlin, S. R., “Thrombin Signalling and Protease-Activated Receptors”, Nature, 2000, vol. 407, pp. 258-264.
Ornstein, D. L., et al., “Cancer, Thrombosis, and Anticoagulants”, Current Opinion in Pulmonary Medicine, 2000, vol. 6, pp. 301-308.
Dabbagh, K., et al., “Thrombin Stimulates Smooth Muscle Cell Procollagen Synthesis and mRNA Levels via a PAR-1 Mediated Mechanism”, Thrombasis and Haemostasis, vol. 79, No. 2 1997, pp. 405-409.
Herault, J-P., et al., “Activation of Human Vascular Endothelial Cells by Factor Xa: Effect of Specific Inhibitors”, Biochemical Pharmacology, 1999, vol. 57, pp. 603-610.
Leveugle, B., et al., “Heparin Oligosaccharides that Pass the Blood- Brain Barrier Inhibit—Amyloid Precursor Protein Secretion and Heparin Binding to □-Amyloid Peptide”, Journal of Neurochemistry, 1998, vol. 70, No. 2, pp. 736-744.
Molino, M., et al., “Differential Expression of Functional Protease-Activated Receptor-2 (PAR-2) in Human Vascular Smooth Muscle Cells”, Arteriosclerosis, Thrombasis, and Vascular Biology, vol. 18, No. 5, 1998, pp. 825-832.
Plescia, J., et al., “Activation of MAC-1 (CD11b/CD18)-Bound Factor X by Release Cathepsin G Defines an Alternative Pathway of Leucocyte Initiation of Coagulat

Affiliated with

Also associated with

Rating

2-aminoethoxyacetic acid derivatives and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-aminoethoxyacetic acid derivatives and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-aminoethoxyacetic acid derivatives and their use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2730686